Therapy Areas: Inflammatory Diseases
Peptone adds new executives to leadership team
29 September 2023 - Peptone, a UK-based translational biophysics company, announced on Thursday that it has named Patrik Foerch, PhD as its new chief scientific officer, David Lowe, PhD as its new sen...
Evommune signs strategic collaboration with Maruho Co
28 September 2023 - Evommune, Inc., a California-based biotechnology company, announced on Wednesday that it has signed a strategic collaboration with Maruho Co., Ltd., a Japan-based pharmaceutical co...
Sandoz secures European approval for Tyruko biosimilar in MS treatment
26 September 2023 - Generic and biosimilar medicines provider Sandoz, part of Swiss pharmaceutical company Novartis Pharma AG (SIX:NOVN) (NYSE:NVS), announced on Tuesday that the European Commission h...
Sanofi granted Priority Review for EoE treatment in young children
26 September 2023 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) said on Tuesday that the US Food and Drug Administration (FDA) has accepted for Priority Review the suppleme...
AffaMed Therapeutics treats first China patient in DEXTENZA Phase three registrational study
21 September 2023 - AffaMed Therapeutics, a China-based global biotechnology company, announced on Wednesday that it has treated its first patient in the Phase three registrational study in China to a...
Pfizer's LITFULO gains EC approval for treating severe alopecia areata in adolescents and adults
19 September 2023 - Biopharmaceutical company Pfizer Inc (NYSE: PFE) announced on Tuesday that it has received European Commission (EC) marketing authorisation for LITFULO (ritlecitinib) to treat seve...